BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/4/2024 5:56:57 AM | Browse: 193 | Download: 765
 |
Received |
|
2024-08-26 04:44 |
|
Peer-Review Started |
|
2024-08-26 04:44 |
|
First Decision by Editorial Office Director |
|
2024-10-17 10:56 |
|
Return for Revision |
|
2024-10-17 10:56 |
|
Revised |
|
2024-10-29 03:40 |
|
Publication Fee Transferred |
|
2024-10-31 05:05 |
|
Second Decision by Editor |
|
2024-11-21 02:36 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-11-22 13:15 |
|
Articles in Press |
|
2024-11-22 13:15 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-11-28 00:30 |
|
Publish the Manuscript Online |
|
2024-12-04 05:56 |
| ISSN |
2218-6220 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Obstetrics & Gynecology |
| Manuscript Type |
Observational Study |
| Article Title |
Serum fibroblast growth factor 21: Lack of association with gestational diabetes and pregnancy outcomes
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Kuntharee Traisrisilp, Nattayaporn Apaijai, Nipawan Waisayanand and Siriporn Chattipakorn |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| The Faculty of Medicine Research Fund, Chiang Mai University, Thailand |
No. 017/2564 |
|
| Corresponding Author |
Kuntharee Traisrisilp, Department of Obstetric and Gynecology, Maharaj Nakorn Chiang Mai Hospital, Chiang Mai University, 110 Intawaroros Road, Sriphoom District, Muang 50200, Chiang Mai, Thailand. kuntharee.t@cmu.ac.th |
| Key Words |
Adipokine; Diabetes mellitus; Fibroblast growth factor 21; Gestational diabetes; Pregnancy |
| Core Tip |
Fibroblast growth factor 21 (FGF21) plays a role in glucose and lipid metabolism, prompting studies on its potential as a predictive marker for gestational diabetes mellitus (GDM). This investigation examined serum FGF21 levels in the early second trimester and their association with GDM. Although a trend toward higher FGF21 levels was noted in insulin-treated GDM patients, no significant association was found between FGF21 and GDM status nor pregnancy outcomes. Possible reasons include a small sample size, low body mass index among participants, and unexamined factors like physical activity. Further research is needed to clarify the role of FGF21 in GDM. |
| Publish Date |
2024-12-04 05:56 |
| Citation |
Traisrisilp K, Apaijai N, Waisayanand N, Chattipakorn S. Serum fibroblast growth factor 21: Lack of association with gestational diabetes and pregnancy outcomes. World J Obstet Gynecol 2024; 13(1): 100776 |
| URL |
https://www.wjgnet.com/2218-6220/full/v13/i1/100776.htm |
| DOI |
https://dx.doi.org/10.5317/wjog.v13.i1.100776 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
